Irritable Bowel Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin 550 MG;   Drug: Mebeverine 135 MG;   Drug: Psyllium Husk;   Drug: Amitriptyline Hydrochloride 25 MG Sponsor:   Bahria University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin 550 MG;   Drug: Mebeverine 135 MG;   Drug: Psyllium Husk;   Drug: Amitriptyline Hydrochloride 25 MG Sponsor:   Bahria University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin 550 MG;   Drug: Mebeverine 135 MG;   Drug: Psyllium Husk;   Drug: Amitriptyline Hydrochloride 25 MG Sponsor:   Bahria University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin 550 MG;   Drug: Mebeverine 135 MG;   Drug: Psyllium Husk;   Drug: Amitriptyline Hydrochloride 25 MG Sponsor:   Bahria University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: Rifaximin 550 MG;   Drug: Mebeverine 135 MG;   Drug: Psyllium Husk;   Drug: Amitriptyline Hydrochloride 25 MG Sponsor:   Bahria University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Dietary Supplement: palmithoylethanolamide/polydatin;   Dietary Supplement: placebo Sponsor:   University of Roma La Sapienza Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials